Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

June 06, 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

May 24, 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

May 23, 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

May 22, 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

May 22, 2019

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Presentation EuroPCR 2019

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Presenter: IJ. Amat-Santos

May 21, 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

May 21, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.